Global Bifurcation Lesions Treatment Market is estimated to be US$ 3.44 billion

Posted by NISHA SHAHA on January 6th, 2022

Global Bifurcation Lesions Treatment Market accounted for US$ 2.06 billion in 2020 and is estimated to be US$ 3.44 billion by 2030 and is anticipated to register a CAGR of 5.30%. A bifurcation lesion is a constriction of a coronary artery that occurs near and/or involves the origin of a substantial side branch that you don\'t want to lose. The Medina classification is intended for use in clinical research and interchange. It is connected with several measuring and imaging modalities that take into consideration the complexity of lesions and therapies, as well as a clear side branch delineation. Measurement of the bifurcation angles requires specialised angiography, as well as 3D angiography and multislice computed tomography. The MADS classification is based on the final position of the stents in the bifurcation and the order in which stents are implanted according to a strategy reflecting lesion and procedure complexity.

The report \" Global Bifurcation Lesions Treatment Market, By Product (T Stent, Culottes, Crush, V Stent, Y Stent, Jailed Balloon), By Type (Coronary Vascular, Peripheral Vascular), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’

Key Highlights:

• In 2020, Advanced Bifurcation Systems, Inc. (ABS), based in Livermore, California, is happy to announce the first closure of a million Series A equity investment. The ABS Device is a patented stent delivery system that is specifically developed to efficiently treat coronary bifurcation lesions. Cedars-Sinai Medical Center, an internationally recognised academic medical centre, and a leading medical equipment manufacturer headed the round.
• In 2021, Contego Medical recently announced that its Neuroguard IEP 3-in-1 carotid stent system and post-dilation balloon system with integrated embolic protection achieved CE mark approval.

Analyst View:

In addition, ongoing clinical trials on stents and balloons for bifurcation lesions, as well as an increase in the occurrence of these lesions, are expected to boost the market in the future years. Advancements in imaging and procedure devices, as well as an increase in the number of qualified surgeons, have reduced related risks, which is expected to boost the market forward.

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Bifurcation-Lesions-Treatment-Market-4832